Leukemia inhibitory factor: a paracrine mediator of bone metabolism. - Wikidata - awgldk - TriplyDB

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

http://www.wikidata.org/entity/Q37981265

about

Advanced glycation end products play adverse proinflammatory activities in osteoporosis Leukemia inhibitory factor (LIF)OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells.Unusual Stüve-Wiedemann syndrome with complete maternal chromosome 5 isodisomy Soluble expression of human leukemia inhibitory factor with protein disulfide isomerase in Escherichia coli and its simple purification.LIF is a new p53 negative regulator Genomic structure and marker-derived gene networks for growth and meat quality traits of Brazilian Nelore beef cattle Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes.Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.Talking among ourselves: paracrine control of bone formation within the osteoblast lineage.Implications of exercise-induced adipo-myokines in bone metabolism.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.The role of exercise-induced myokines in regulating metabolism.Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis.Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies

P2860

Q27024641-B34B5A10-D568-4D8D-B540-2F50556B420C Q28082576-7648178C-241B-4CD1-BAFE-B0B76D6977D6 Q34637681-2C048EF4-D130-4B43-9828-A79274F156B9 Q34692075-D939D1EB-CFF0-4EC8-B6CB-F977DD40695B Q35073178-F7668D48-C6B4-486E-858E-F743D8214292 Q35825750-66EB998C-509D-4B0F-A3A9-05CF75871AC8 Q35958423-CB507241-99CA-4FBC-849C-796174F6C3AB Q36271527-1C2A6074-24E5-4F84-A70E-676D8BE27280 Q37710308-609DFA01-CA26-4DFB-BDA6-916709D9A3EC Q38108518-709752CD-906D-4D4C-8ACF-39257185BBDC Q38683297-399BDE7C-1E40-4DDD-B30C-D1B55857A61C Q38720813-E32865DB-7E22-465C-BBEC-43370344D87E Q47362763-7AD82348-0132-4015-9182-011A4B5D22B0 Q55064262-6D29F6FE-AF89-464E-A6BE-08BD62A6397F Q58577346-A496666B-177B-403A-A34B-A01E99599A13

P2860

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

http://www.wikidata.org/entity/Q37981265

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

@en

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

@nl

type

label

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

@en

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

@nl

prefLabel

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

@en

Leukemia inhibitory factor: a paracrine mediator of bone metabolism.

@nl

P1433

Q37981265-FD30F3EC-F518-42BD-8A0B-4B86213D9600

P1476

Q37981265-2371E85B-315D-4853-B3BF-E3AC9AAA4339

P2093

Q37981265-AC03919E-C802-4CF8-B522-BF2B3D5AE233

P2860

Q37981265-0C464386-7DFF-4BB2-8EEF-A960FB35D598

Q37981265-10DB71E9-9D95-4751-B7B1-80F0E54E053B

Q37981265-15DA02B9-1035-492C-BE3E-22FCF509B2AB

Q37981265-182A727C-619A-40A2-AC08-60B038DF0DB9

Q37981265-1CB26487-82C2-4EF0-8156-C8562C734CEC

Q37981265-22DD1912-8819-4B9D-8463-A84F54CED438

Q37981265-2524BF2E-83F3-4D4B-B309-E7FF0C62FAE8

Q37981265-26B5A600-2846-4488-BB35-34B2EEB14C69

Q37981265-2E0E5692-C6F9-480C-BCE5-E98619089314

Q37981265-32F80B8F-D0EF-40AF-92D3-21CF4E5D011E

P304

Q37981265-385237DE-A9B7-4B1F-A985-6E4B7BD8F64F

P31

Q37981265-C8F4F207-AFFB-4EF0-AA31-5528DEE4E2BA

P356

Q37981265-0917DF83-1692-4676-8AE7-1D21C11636D5

P433

Q37981265-EB47197F-0D08-4098-AA06-331CEBB1F79A

P478

Q37981265-51108D25-B289-4560-BA60-B32339611D27

P50

Q37981265-DC01061E-5262-46D1-8742-617C19F1F93D

P577

Q37981265-FECA6E4F-8CA1-4AF0-8E18-606D224A58F7

P5875

Q37981265-7FF4C5F0-EC45-475E-B415-1611A34A731C

P698

Q37981265-194CF29B-9BE1-4B12-B844-86E4C6119C62

P921

Q37981265-033B53AD-1400-4E30-B550-A5F1822E8773

P356

08977194.2012.656760

P1433

Growth Factors Journal

P1476

Leukemia inhibitory factor: a paracrine mediator of bone metabolism

@en

P2093

Rachelle W Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation

Cloning and characterization of a specific receptor for mouse oncostatin M

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice

An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor

Matrix-embedded cells control osteoclast formation

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

P304

76-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08977194.2012.656760

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Natalie A. Sims

P577

2012-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221805043

http://www.w3.org/2001/XMLSchema#string

P698

22304408

http://www.w3.org/2001/XMLSchema#string

P921